« Previous
Next »
Leukemia Research
Volume 29, Issue 2
, Pages 135-140
, February 2005
High Th1/Th2 ratio in patients with multiple myeloma
References
- . The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 1996;17:138–146
- . Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells. Cytometry. 2000;40:60–68
- . A clinical staging system for multiple myeloma. Cancer. 1975;36:842–854
- . Lymphoid subsets and prognostic factor in multiple myeloma. Brit. J. Haematol. 1992;80:305–309
- . Relation between CD4+/CD8+ T cell ratio and T cell activation in multiple myeloma: reference to IL-6. Leukemia Res. 2002;26:705–711
- . Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance. Brit. J. Haematol. 1989;71:223–225
- . Human Th1 and Th2 subsets: doubt no more. Immunol. Today. 1991;12:256–257
- . Lymphokine production by human T cell in disease state. Ann. Rev. Immunol. 1994;12:227–257
- . Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989;7:145–173
- . T-helper (Th) 1/2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma. Cancer Immunol. Immunother. 2001;50:566–568
- . Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother. 2000;49:165–172
- . Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells. Exp. Hematol. 1999;27:1375–1383
- . Reduced IL-4 and interferon-gamma (IFN-γ) expression by CD4 T cells in patients with chronic lymphocytic leukemia. Clin. Exp. Immunol. 1999;117:8–11
- . IL-4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia. Brit. J. Haematol. 1999;104:589–599
- . Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood. 1995;86:3043–3049
- . Transforming growth factor β from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes. J. Leukoc. Biol. 1999;66:981–988
- . Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J. Interferon. Cytokine Res. 2001;21:147–155
- . Imbalances of T-cell subsets in monoclonal gammopathies. Cancer Immunol. Immunother. 1984;17:112–116
- . T cells in monoclonal gammopathies. Scand. J. Haematol. 1982;29:57–64
- . B and T lymphocytic populations and subpopulations and natural killer cells in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance. Pathologica. 1985;77:385–393
- . Analysis of the relationship between T cell subsets and in vitro B cell responses in multiple myeloma. J. Clin. Lab. Immunol. 1985;16:23–26
PII: S0145-2126(04)00227-9
doi: 10.1016/j.leukres.2004.06.003
© 2004 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 29, Issue 2
, Pages 135-140
, February 2005
